4DMedical Limited (ASX: 4DX)

Market Cap	186.79M
Revenue (ttm)	3.75M
Net Income (ttm)	-35.98M
Shares Out	410.53M
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	489,353
Open	0.455
Previous Close	0.450
Day's Range	0.450 - 0.470
52-Week Range	0.410 - 1.100
Beta	1.26
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 26, 2024

About 4DMedical

4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non‑invasive respiratory imaging solution using four‑dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functiona...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 145
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: 4DX

Financial Performance

In 2024, 4DMedical's revenue was 3.75 million, an increase of 422.45% compared to the previous year's 718,581. Losses were -35.98 million, 14.4% more than in 2023.